ArticleBioinformation2025
Impact of thyroid autoantibodies on pregnancy: A prospective cohort study.
Article in Bioinformation, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
We conducted a prospective cohort study of 1,200 pregnant women recruited in early first trimester to evaluate the impact of thyroid autoantibodies (TPOAb and/or TGAb) on maternal and neonatal outcomes. Overall, 18.2% were antibody-positive. Compared with antibody-negative women, those with thyroid autoimmunity had significantly higher risks of pregnancy-induced hypertension (12.6% vs 7.9%), gestational diabetes (15.3% vs 10.2%) and neonatal intensive care unit admission (11.2% vs 6.5%). Adjusted logistic regression confirmed independent associations after controlling for maternal age, BMI, parity and TSH levels. Neonates born to antibody-positive mothers had lower mean birth weight (2980 ± 420 g vs 3125 ± 395 g, p=0.02) and higher risk of small-for-gestational age (8.7% vs 4.9%). Thus, we show that thyroid autoantibodies, even in euthyroid women, are associated with adverse pregnancy outcomes and justify closer monitoring during antenatal care.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.